Cubist Systematic Strategies’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-195,720
| Closed | -$11.7M | – | 3559 |
|
|
2023
Q2 | $11.7M | Sell |
195,720
-4,635
| -2% | -$264K | 0.08% | 362 |
|
|
2023
Q1 | $11.3M | Buy |
+200,355
| New | +$12.8M | 0.07% | 398 |
|
|
2022
Q4 | – | Sell |
-36,568
| Closed | -$2.18M | – | 4372 |
|
|
2022
Q3 | $2.18M | Sell |
36,568
-9,547
| -21% | -$575K | 0.01% | 1920 |
|
|
2022
Q2 | $2.59M | Buy |
46,115
+21,807
| +90% | +$1.43M | 0.02% | 1603 |
|
|
2022
Q1 | $1.79M | Sell |
24,308
-17,327
| -42% | -$1.2M | 0.02% | 1574 |
|
|
2021
Q4 | $3.01M | Sell |
41,635
-12,492
| -23% | -$907K | 0.03% | 1020 |
|
|
2021
Q3 | $4.15M | Buy |
54,127
+4,553
| +9% | +$366K | 0.05% | 557 |
|
|
2021
Q2 | $3.84M | Buy |
49,574
+13,956
| +39% | +$992K | 0.04% | 697 |
|
|
2021
Q1 | $2.2M | Sell |
35,618
-67,144
| -65% | -$4.25M | 0.03% | 974 |
|
|
2020
Q4 | $6.7M | Sell |
102,762
-34,515
| -25% | -$1.98M | 0.09% | 299 |
|
|
2020
Q3 | $6.8M | Buy |
137,277
+92,106
| +204% | +$4.75M | 0.1% | 281 |
|
|
2020
Q2 | $2.15M | Buy |
45,171
+5,865
| +15% | +$283K | 0.04% | 743 |
|
|
2020
Q1 | $1.67M | Sell |
39,306
-16,332
| -29% | -$807K | 0.05% | 551 |
|
|
2019
Q4 | $3.28M | Buy |
55,638
+11,529
| +26% | +$626K | 0.06% | 478 |
|
|
2019
Q3 | $2.25M | Buy |
44,109
+32,521
| +281% | +$1.55M | 0.04% | 577 |
|
|
2019
Q2 | $490K | Buy |
11,588
+4,682
| +68% | +$203K | 0.01% | 1484 |
|
|
2019
Q1 | $341K | Sell |
6,906
-65,010
| -90% | -$2.94M | 0.01% | 1428 |
|
|
2018
Q4 | $3.11M | Buy |
71,916
+71,216
| +10,174% | +$3.55M | 0.15% | 133 |
|
|
2018
Q3 | $40K | Sell |
700
-3,288
| -82% | -$173K | ﹤0.01% | 1735 |
|
|
2018
Q2 | $201K | Sell |
3,988
-16,386
| -80% | -$854K | 0.01% | 1356 |
|
|
2018
Q1 | $1.01M | Buy |
20,374
+19,274
| +1,752% | +$906K | 0.06% | 431 |
|
|
2017
Q4 | $45K | Sell |
1,100
-4,860
| -82% | -$170K | ﹤0.01% | 1788 |
|
|
2017
Q3 | $177K | Buy |
+5,960
| New | +$182K | 0.01% | 1494 |
|
|
2017
Q2 | – | Sell |
-12,490
| Closed | -$370K | – | 1751 |
|
|
2017
Q1 | $370K | Buy |
12,490
+1,793
| +17% | +$48.9K | 0.03% | 800 |
|
|
2016
Q4 | $265K | Buy |
+10,697
| New | +$243K | 0.02% | 1047 |
|
|
2016
Q3 | – | Sell |
-29,589
| Closed | -$705K | – | 1754 |
|
|
2016
Q2 | $705K | Sell |
29,589
-344
| -1% | -$8.25K | 0.04% | 593 |
|
|
2016
Q1 | $711K | Buy |
+29,933
| New | +$732K | 0.04% | 603 |
|
|
2015
Q4 | – | Sell |
-52,758
| Closed | -$1.09M | – | 1821 |
|
|
2015
Q3 | $1.09M | Buy |
52,758
+37,498
| +246% | +$950K | 0.06% | 532 |
|
|
2015
Q2 | $392K | Sell |
15,260
-16,640
| -52% | -$421K | 0.02% | 1072 |
|
|
2015
Q1 | $805K | Buy |
31,900
+20,663
| +184% | +$503K | 0.04% | 679 |
|
|
2014
Q4 | $267K | Buy |
11,237
+5,072
| +82% | +$112K | 0.01% | 1311 |
|
|
2014
Q3 | $121K | Sell |
6,165
-22,178
| -78% | -$456K | 0.01% | 1507 |
|
|
2014
Q2 | $678K | Buy |
+28,343
| New | +$684K | 0.04% | 618 |
|
Other funds holding GMED
BAM
CCM
CIP
Cubist Systematic Strategies's GMED Position: Q3 2023 in Review
Cubist Systematic Strategies sold out of Globus Medical (GMED) in Q3 2023, closing a stake of 195,720 shares — an estimated $11.7M sold.
Cubist Systematic Strategies first reported a position in GMED in Q2 2014 and held it in 33 quarters. The position peaked at $11.7M in Q2 2023. 431 funds tracked by Wall St. Rank hold GMED as of Q3 2023.
- Cubist Systematic Strategies reported no remaining Globus Medical position as of Q3 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 195,720 Globus Medical shares in Q3 2023, an estimated $11.7M.
- Cubist Systematic Strategies first reported a position in Globus Medical in Q2 2014 and held it in 33 quarters.
- Cubist Systematic Strategies's Globus Medical position peaked at $11.7M in Q2 2023.
- 431 funds tracked by Wall St. Rank held Globus Medical as of Q3 2023.
Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.